The complexities of T-cell dysfunction in chronic lymphocytic leukemia

被引:3
作者
Camerini, Elena [1 ,2 ]
Amsen, Derk [1 ,3 ]
Kater, Arnon P. [2 ]
Peters, Fleur S. [1 ,2 ]
机构
[1] Amsterdam UMC, Dept Expt Immunol, Amsterdam, Netherlands
[2] Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands
[3] Landsteiner Lab Blood Cell Res Sanquin, Amsterdam, Netherlands
关键词
T -cell Dysfunction; Chronic lymphocytic leukemia; Autologous T -cell therapy; TRANSGENIC MOUSE; CLL PATIENTS; PERIPHERAL-BLOOD; SURFACE IGM; LYMPH-NODE; TFH CELLS; B-CELLS; PROLIFERATION; ACTIVATION; EXPRESSION;
D O I
10.1053/j.seminhematol.2024.04.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy characterized by profound alterations and defects in the T-cell compartment. This observation has gained renewed interest as T-cell treatment strategies, which are successfully applied in more aggressive B-cell malignancies, have yielded disappointing results in CLL. Despite ongoing efforts to understand and address the observed T-cell defects, the exact mechanisms and nature underlying this dysfunction remain largely unknown. In this review, we examine the supporting signals from T cells to CLL cells in the lymph node niche, summarize key findings on T-cell functional defects, delve into potential underlying causes, and explore novel strategies for reversing these deficiencies. Our goal is to identify strategies aimed at resolving CLL-induced T-cell dysfunction which, in the future, will enhance the efficacy of autologous T-cell-based therapies for CLL patients. (c) 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:163 / 171
页数:9
相关论文
共 117 条
[1]  
Abadie K, 2023, bioRxiv, DOI [10.1101/2022.12.31.521782, 10.1101/2022.12.31.521782v2, DOI 10.1101/2022.12.31.521782V2]
[2]   Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study [J].
Abramson, Jeremy S. ;
Palomba, M. Lia ;
Gordon, Leo I. ;
Lunning, Matthew A. ;
Wang, Michael ;
Arnason, Jon ;
Mehta, Amitkumar ;
Purev, Enkhtsetseg ;
Maloney, David G. ;
Andreadis, Charalambos ;
Sehgal, Alison ;
Solomon, Scott R. ;
Ghosh, Nilanjan ;
Albertson, Tina M. ;
Garcia, Jacob ;
Kostic, Ana ;
Mallaney, Mary ;
Ogasawara, Ken ;
Newhall, Kathryn ;
Kim, Yeonhee ;
Li, Daniel ;
Siddiqi, Tanya .
LANCET, 2020, 396 (10254) :839-852
[3]   IL-4 enhances expression and function of surface IgM in CLL cells [J].
Aguilar-Hernandez, Maria M. ;
Blunt, Matthew D. ;
Dobson, Rachel ;
Yeomans, Alison ;
Thirdborough, Stephen ;
Larrayoz, Marta ;
Smith, Lindsay D. ;
Linley, Adam ;
Strefford, Jonathan C. ;
Davies, Andrew ;
Johnson, Peter M. W. ;
Savelyeva, Natalia ;
Cragg, Mark S. ;
Forconi, Francesco ;
Packham, Graham ;
Stevenson, Freda K. ;
Steele, Andrew J. .
BLOOD, 2016, 127 (24) :3015-3025
[4]   Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia [J].
Ahearne, Matthew J. ;
Willimott, Shaun ;
Pinon, Lucia ;
Kennedy, D. Benjamin ;
Miall, Fiona ;
Dyer, Martin J. S. ;
Wagner, Simon D. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (03) :360-370
[5]   Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia [J].
Ahn, Inhye E. ;
Underbayev, Chingiz ;
Albitar, Adam ;
Herman, Sarah E. M. ;
Tian, Xin ;
Maric, Irina ;
Arthur, Diane C. ;
Wake, Laura ;
Pittaluga, Stefania ;
Yuan, Constance M. ;
Stetler-Stevenson, Maryalice ;
Soto, Susan ;
Valdez, Janet ;
Nierman, Pia ;
Lotter, Jennifer ;
Xi, Liqiang ;
Raffeld, Mark ;
Farooqui, Mohammed ;
Albitar, Maher ;
Wiestner, Adrian .
BLOOD, 2017, 129 (11) :1469-1479
[6]  
[Anonymous], CHRONIC LYMPHOCYTIC
[7]   Targeting the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia [J].
Arruga, Francesca ;
Serra, Sara ;
Vitale, Nicoletta ;
Guerra, Giulia ;
Papait, Andrea ;
Gyau, Benjamin Baffour ;
Tito, Francesco ;
Efremov, Dimitar ;
Vaisitti, Tiziana ;
Deaglio, Silvia .
HAEMATOLOGICA, 2021, 106 (05) :1343-1353
[8]   Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL [J].
Blanco, Gonzalo ;
Vardi, Anna ;
Puiggros, Anna ;
Gomez-Llonin, Andrea ;
Muro, Manuel ;
Rodriguez-Rivera, Maria ;
Stalika, Evangelia ;
Abella, Eugenia ;
Gimeno, Eva ;
Lopez-Sanchez, Manuela ;
Senin, Alicia ;
Calvo, Xavier ;
Abrisqueta, Pau ;
Bosch, Francesc ;
Ferrer, Ana ;
Stamatopoulos, Kostas ;
Espinet, Blanca .
ONCOIMMUNOLOGY, 2018, 7 (06)
[9]   CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints [J].
Boettcher, Martin ;
Boettcher-Loschinski, Romy ;
Kahlfuss, Sascha ;
Aigner, Michael ;
Giessl, Andreas ;
Mackensen, Andreas ;
Schloetzer-Schrehardt, Ursula ;
Tueting, Thomas ;
Bruns, Heiko ;
Mougiakakos, Dimitrios .
CELLS, 2022, 11 (14)
[10]   Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia [J].
Boncompagni, Gioia ;
Tatangelo, Vanessa ;
Lopresti, Ludovica ;
Ulivieri, Cristina ;
Capitani, Nagaja ;
Tangredi, Carmela ;
Finetti, Francesca ;
Marotta, Giuseppe ;
Frezzato, Federica ;
Visentin, Andrea ;
Ciofini, Sara ;
Gozzetti, Alessandro ;
Bocchia, Monica ;
Calzada-Fraile, Diego ;
Cofreces, Noa B. Martin ;
Trentin, Livio ;
Patrussi, Laura ;
Baldari, Cosima T. .
CELL DEATH & DISEASE, 2024, 15 (02)